Saponaro, M.; Annunziata, L.; Turla, A.; Viganò, I.; De Laurentiis, M.; Giuliano, M.; Del Mastro, L.; Montemurro, F.; Puglisi, F.; De Angelis, C.;
et al. Extended Adjuvant Endocrine Treatment in Luminal Breast Cancers in the Era of Genomic Tests. Int. J. Mol. Sci. 2022, 23, 13604.
https://doi.org/10.3390/ijms232113604
AMA Style
Saponaro M, Annunziata L, Turla A, Viganò I, De Laurentiis M, Giuliano M, Del Mastro L, Montemurro F, Puglisi F, De Angelis C,
et al. Extended Adjuvant Endocrine Treatment in Luminal Breast Cancers in the Era of Genomic Tests. International Journal of Molecular Sciences. 2022; 23(21):13604.
https://doi.org/10.3390/ijms232113604
Chicago/Turabian Style
Saponaro, Mariarosaria, Luigi Annunziata, Antonella Turla, Ilaria Viganò, Michele De Laurentiis, Mario Giuliano, Lucia Del Mastro, Filippo Montemurro, Fabio Puglisi, Carmine De Angelis,
and et al. 2022. "Extended Adjuvant Endocrine Treatment in Luminal Breast Cancers in the Era of Genomic Tests" International Journal of Molecular Sciences 23, no. 21: 13604.
https://doi.org/10.3390/ijms232113604
APA Style
Saponaro, M., Annunziata, L., Turla, A., Viganò, I., De Laurentiis, M., Giuliano, M., Del Mastro, L., Montemurro, F., Puglisi, F., De Angelis, C., Buono, G., Schettini, F., & Arpino, G.
(2022). Extended Adjuvant Endocrine Treatment in Luminal Breast Cancers in the Era of Genomic Tests. International Journal of Molecular Sciences, 23(21), 13604.
https://doi.org/10.3390/ijms232113604
